BRT partners with SenzaGen on in vitro GARD® test platform

BRT and SenzaGen

Burleson Research Technologies has partnered with SenzaGen in an agreement to market and offer the in vitro GARD test method, making BRT the first U.S. laboratory to offer this service. The GARD method displays a higher accuracy than other available methods and reveals if chemical substances are causing allergies in humans. “We are looking forward […]